[HTML][HTML] The ASD Living Biology: from cell proliferation to clinical phenotype

E Courchesne, T Pramparo, VH Gazestani…�- Molecular�…, 2019 - nature.com
Autism spectrum disorder (ASD) has captured the attention of scientists, clinicians and the
lay public because of its uncertain origins and striking and unexplained clinical�…

[HTML][HTML] Autism spectrum disorder: Primary care principles

KE Sanchack, CA Thomas�- American family physician, 2016 - aafp.org
Autism spectrum disorder is characterized by difficulty with social communication and
restricted, repetitive patterns of behavior, interest, or activities. The Diagnostic and Statistical�…

[HTML][HTML] Cytoplasmic Rbfox1 regulates the expression of synaptic and autism-related genes

JA Lee, A Damianov, CH Lin, M Fontes, NN Parikshak…�- Neuron, 2016 - cell.com
Human genetic studies have identified the neuronal RNA binding protein, Rbfox1, as a
candidate gene for autism spectrum disorders. While Rbfox1 functions as a splicing�…

[HTML][HTML] The (poly) pharmacology of cannabidiol in neurological and neuropsychiatric disorders: molecular mechanisms and targets

RM Vitale, FA Iannotti, P Amodeo�- International journal of molecular�…, 2021 - mdpi.com
Cannabidiol (CBD), the major nonpsychoactive Cannabis constituent, has been proposed
for the treatment of a wide panel of neurological and neuropsychiatric disorders, including�…

[HTML][HTML] Genetics of autism spectrum disorder: current status and possible clinical applications

H Yoo�- Experimental neurobiology, 2015 - ncbi.nlm.nih.gov
Autism spectrum disorder (ASD) is one of the most complex behavioral disorders with a
strong genetic influence. The objectives of this article are to review the current status of�…

Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms

CB Avella-Garcia, J Julvez, J Fortuny…�- International journal�…, 2016 - academic.oup.com
Background: Acetaminophen is extensively used during pregnancy. But there is a lack of
population-representative cohort studies evaluating its effects on a range of�…

Low‐dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial

RK Naviaux, B Curtis, K Li, JC Naviaux…�- Annals of Clinical�…, 2017 - Wiley Online Library
Objective No drug is yet approved to treat the core symptoms of autism spectrum disorder
(ASD). Low‐dose suramin was effective in the maternal immune activation and Fragile X�…

Maternal and early postnatal immune activation produce dissociable effects on neurotransmission in mPFC–amygdala circuits

Y Li, G Missig, BC Finger, SM Landino…�- Journal of�…, 2018 - Soc Neuroscience
Inflammatory processes may be involved in the pathophysiology of neuropsychiatric
illnesses including autism spectrum disorder (ASD). Evidence from studies in rodents�…

New considerations for hiPSC-based models of neuropsychiatric disorders

GE Hoffman, N Schrode, E Flaherty…�- Molecular psychiatry, 2019 - nature.com
The development of human-induced pluripotent stem cells (hiPSCs) has made possible
patient-specific modeling across the spectrum of human disease. Here, we discuss recent�…

Reduced language lateralization in autism and the broader autism phenotype as assessed with robust individual‐subjects analyses

O Jouravlev, AJE Kell, Z Mineroff, AJ Haskins…�- Autism�…, 2020 - Wiley Online Library
One of the few replicated functional brain differences between individuals with autism
spectrum disorders (ASD) and neurotypical (NT) controls is reduced language lateralization�…